Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Legood

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
BMJ Health & Care Informatics|July 20, 2021
Telemammography for breast cancer screening: a cost-effective approach in ArgentinaVictoria Alba Malek Pascha, Li Sun, Ramiro Gilardino, et al.
China CDC Weekly|September 5, 2022
Using Genetic Testing at Cancer Diagnosis for Breast Cancer ControlLi Sun, Xia Wei, Ranjit Manchanda, et al.
American Journal of Obstetrics and Gynecology|September 2, 2023
Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: responseXia Wei, Samuel Oxley, Michail Sideris, et al.
International Journal of Cancer|October 28, 2018
Cost-effectiveness of breast cancer screening programme for women in rural ChinaLi Sun, Zia Sadique, Isabel Dos-Santos-Silva, et al.
Plos One|September 3, 2010
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian childrenLesong Conteh, Edith Patouillard, Margaret Kweku, et al.
Frontiers in Public Health|June 12, 2023
Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literatureRachel Greenley, Sadie Bell, Samuel Rigby, et al.
BMJ (Clinical Research Ed.)|January 10, 2006
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after studySue Moss, Alastair Gray, Rosa Legood, et al.
Bulletin of the World Health Organization|August 15, 2018
Cost-effectiveness of risk-based breast cancer screening programme, ChinaLi Sun, Rosa Legood, Zia Sadique, et al.
Journal of Medical Genetics|June 30, 2016
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysisRanjit Manchanda, Rosa Legood, Antonis C Antoniou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature ReviewNoemia Teixeira de Siqueira-Filha, Rosa Legood, Aracele Cavalcanti, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
BMJ Health & Care Informatics|July 20, 2021
Telemammography for breast cancer screening: a cost-effective approach in ArgentinaVictoria Alba Malek Pascha, Li Sun, Ramiro Gilardino, et al.
China CDC Weekly|September 5, 2022
Using Genetic Testing at Cancer Diagnosis for Breast Cancer ControlLi Sun, Xia Wei, Ranjit Manchanda, et al.
American Journal of Obstetrics and Gynecology|September 2, 2023
Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: responseXia Wei, Samuel Oxley, Michail Sideris, et al.
International Journal of Cancer|October 28, 2018
Cost-effectiveness of breast cancer screening programme for women in rural ChinaLi Sun, Zia Sadique, Isabel Dos-Santos-Silva, et al.
Plos One|September 3, 2010
Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian childrenLesong Conteh, Edith Patouillard, Margaret Kweku, et al.
Frontiers in Public Health|June 12, 2023
Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literatureRachel Greenley, Sadie Bell, Samuel Rigby, et al.
BMJ (Clinical Research Ed.)|January 10, 2006
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after studySue Moss, Alastair Gray, Rosa Legood, et al.
Bulletin of the World Health Organization|August 15, 2018
Cost-effectiveness of risk-based breast cancer screening programme, ChinaLi Sun, Rosa Legood, Zia Sadique, et al.
Journal of Medical Genetics|June 30, 2016
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysisRanjit Manchanda, Rosa Legood, Antonis C Antoniou, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 23, 2018
Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV: A Systematic Literature ReviewNoemia Teixeira de Siqueira-Filha, Rosa Legood, Aracele Cavalcanti, et al.
Pageof 9